MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 297.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,193,125 | -29.9% | 290,298 | 0.0% | 0.04% | -36.9% |
| Q4 2022 | $1,701,146 | -13.3% | 290,298 | 0.0% | 0.06% | -20.7% |
| Q3 2022 | $1,962,000 | -14.3% | 290,298 | -41.4% | 0.08% | -5.7% |
| Q2 2022 | $2,289,000 | +15.8% | 495,481 | 0.0% | 0.09% | +42.6% |
| Q1 2022 | $1,977,000 | -35.9% | 495,481 | 0.0% | 0.06% | -29.1% |
| Q4 2021 | $3,082,000 | +194.6% | 495,481 | +346.8% | 0.09% | +196.6% |
| Q3 2021 | $1,046,000 | -30.5% | 110,906 | 0.0% | 0.03% | -17.1% |
| Q2 2021 | $1,506,000 | -16.1% | 110,906 | 0.0% | 0.04% | -12.5% |
| Q1 2021 | $1,794,000 | -39.2% | 110,906 | 0.0% | 0.04% | -41.2% |
| Q4 2020 | $2,951,000 | +42.9% | 110,906 | 0.0% | 0.07% | +33.3% |
| Q3 2020 | $2,065,000 | -20.4% | 110,906 | 0.0% | 0.05% | -13.6% |
| Q2 2020 | $2,595,000 | – | 110,906 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |